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Summary
The purpose of this article is to describe the research of Nicolae Constantin Paulescu and to 
emphasize his role in the discovery of insulin. Methods: We made a thorough review of the 
literature and research in the Romanian Academy Archive in order to find adequate refer-
ences. Results: In 1912 N.C. Paulescu analysed the clinical and biochemical alterations in 
diabetic patients and in dogs after performing a pancreatectomy, that apart hyperglycemia 
and glycosuria (carbohydrate metabolism), had noted also changes in lipid and protein me-
tabolism. In 1916 he started the experiments with a pancreas extract obtained by his original 
method, that was injected intravenously to the diabetic dogs. The results of his first experi-
ments showed: “The pancreatic extract injected into a peripheral vein produce: 1) A diminu-
tion and even a temporary suppression of diabetic hyperglycemia, which may be replaced by 
hypoglycemia; 2) A diminution or even temporary suppression of glycosuria; 3) A diminution 
of blood urea; 4) A diminution of urinary urea. In other words, the intravenous injection of 
the pancreatic extract has as effect the disappearance of diabetic symptoms. The attenua-
tion of the diabetic syndrome begins immediately after the injection. It reaches a maximum 
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after 2 hours,- and it lasts for about 12 hours”. He concluded as such: “This discovery,- which 
sheds a bright light over the pathogenesis of diabetes gives us also the key for the treatment 
of this syndrome”. In 1921, Paulescu had published extensively his data in two outstanding 
French journals 8 months before the first publication of Banting and Best from February 
1922. It is clear that insulin has been discovered in Europe. Conclusion: Paulescu thought 
that a new hormone – Pancreine, that he discovered is the key element in the treatment of 
diabetes, but his outstanding research was unfairly neglected.
Keywords: insulin discovery; medical ethics; chronology and context; experimental design.
Introduction
The discovery of insulin has been considered the greatest discovery of the 
last century and one of the greatest of medicine in modern age [1-3]. However, 
Michael Bliss, in his monograph, “Discovery of insulin”, [1] in chapter 8, enti-
tled “Who discovered insulin?”, couldn’t give a clear response to this question. 
It is obvious that the clinical application of the newly discovered hormone 
made in 1922 in Toronto, raised an explicable enthusiasm among the medical 
community of that time. Now we know that the purification of the pancre-
atic extract, which makes possible its utilization in human, has been done 
by Collip in January 1922 [4] and that its extract was the only one used in the 
first clinical trial carried out in Toronto before the industrial production put 
in work by Lilly Company in the second part of 1922 and then afterward [4].
In 1923, the Nobel Prize was awarded to Frederick Banting and James 
Macleod, but the official Canadian historiography of that time had a prefer-
ence to Banting and Best (the first, an untrained country doctor, and the sec-
ond, an assistant student). Why? Because the big discovery was transformed 
by Canadian mass-media and political circles in a fairy story about what was 
called the “native Canadian genius erupting into a miraculous achievement”. 
In fact, out of four members of the famous ”Toronto’s crab basket” (Banting, 
Macleod, Best and Collip), only the first two received an international rec-
ognition and glory [1]. It is not the place to analyse on what “objective” basis 
was awarded the Nobel Prize in 1923, but a letter of Prof. Alfred Pettersson 
(a member of the Nobel Prize jury) to the Nobel Assembly (mentioned by 
Michael Bliss in his book, page 228), is illustrative:
“It is quite clear to me that a fundamental requirement in awarding a person 
a Nobel Prize is knowledge of what part the person has actually taken in the 
work being honoured. During the time I have participated in the awarding of 
the Nobel Prize, the justification for the award has never been based on hear-
say evidence from unknown persons, on statements like “it is beyond doubt”, 
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on things that are thought as “very possible”. In my opinion, it is very neces-
sary that the Assembly risks the development of unpleasant discoveries at 
a later date. I also point out a certain contradiction in Professor Jacobaeus’s 
final judgement about Macleod’s part in the work relating to insulin produc-
tion. Banting is said to have been ready to make an experiment that would 
not have led to the goal, and to have been corrected by Macleod. But be-
fore that, Jocabaeus writes that Banting came with his idea to Macleod and 
worked through to insulin under Macleod’s direction. If the work was totally 
under Macleod’s direction, then Banting could hardly be made responsible, 
at least not alone, if they, in the beginning, started out on the wrong road.”
It is interesting to remember that the members of the Committee had big 
difficulties in the identification of what achievements Banting and Macleod 
had made, because their dossier was very “thin”, with few and inconclu-
sive published papers [5,6]. Finally, the Nobel Prize has been awarded to the 
“humble Canadian genius” – Frederick Banting, and to the refined Professor 
James Macleod.
The prophecy of Alfred Pettersson has been fully accomplished. It is well 
known that 1923 Nobel Price awarding for Medicine was the subject of many 
critics and disputes, which hopefully will end in 2021, with the occasion of 
the celebration 100 years since the insulin discovery. 
The road of diabetes understanding 
before insulin discovery
The modern history of diabetes included a chain of events starting with 
the rediscovery of the sweet taste of urine by Thomas Willis (1621-1675) and 
by the observation of Eugène Chevreul (1786-1889) that sugar from the urine 
of diabetic patients is identical with the sugar from grapes. Claude Bernard 
(1813-1878) introduced the term “internal secretion” and discovered the glyco-
genic function of the liver, which maintains blood glucose around 120 mg/dl, 
and that the renal threshold for glycosuria is blood glucose between 170-180 
mg/dl. Paul Langerhans (1847-1888) described some specific agglomeration of 
small cells that can be seen from place to place among the acinary histolog-
ic appearance of the pancreas. Etienne Lancereaux (1828-1910) described for 
the first time the pancreas as the organ affected in diabetes, introducing the 
term pancreatic diabetes (which is specific for “thin” diabetes – the actual type 
1 diabetes); in the same time, he described also the “fat” diabetes (the actual 
type 2 diabetes), producing the first classification of the diabetes syndrome. 
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The pancreatic origin of diabetes has been incidentally confirmed by von 
Mering and Minkowski in 1889. Edouard Laguèsse (1861-1927) rediscovered 
the doctoral thesis of Langerhans with the histologically description of pan-
creas and suggested that these “islets of Langerhans” could be the siege of 
the internal secretion of the pancreas. Emmanuel Hédon (1863-1933) provid-
ed indirect evidence of an ‘anti-diabetic principle”, produced by the normal 
pancreas. Between 1893-1919, several dozen of researchers tried to prepare 
various pancreatic extracts in order to treat diabetic patients and eventu-
ally, to understand the function of the supposed pancreatic anti-diabetic 
hormone. The presence of this was quite evident, explaining why in 1909, 
the Belgian physiologist Jean de Meyer [7], proposed that when this hormone 
will be discovered to be named “Insulin”.
It is well to mention that in all these attempts diabetes has been interpret-
ed as a “sugar disease”, so that the only investigation used for proving the 
presence of a pancreatic internal secretion was based on the determination 
of urinary glucose and sometimes of blood glucose. 
Paulescu and the new paradigm of diabetes
The interest of Paulescu (1869-1931) for the internal secretion of the pan-
creas dated back to 1899, when, together with Albert Dastre (1844-1917) at 
the Sorbonne University, he tried 
to obtain a pancreatic extract to be 
used for the treatment of diabetes. 
This project was postponed because 
in 1901 Paulescu returned from Paris 
to Bucharest, in order to create the 
first Physiology Chair in the young 
Faculty of Medicine. He maybe un-
derstood that before obtaining a 
therapeutic “tool”, it was necessary 
to know the pathophysiologic basis 
of diabetes. In other terms, to know 
the nature of the internal secretion 
of the pancreas and its physiological 
properties. This enterprise lasted at 
least 14 years, including the 4-year 
break imposed by the 1st World War.
Figure 1. N.C. Paulescu in 1907.
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The most comprehensive papers published by Paulescu in which were de-
scribed all physiologic functions of the new hormone isolated by him (named 
“Pancreine”) and also its pharmaco-dynamic characteristics, were published 
in two outstanding journals: the first on 23 July 1921 as four short papers [8-
11], and the second one, on 31 August 1921 in Archives of Internal Physiology 
Liège/Paris, with an unexpected title “Research regarding the role of the pancre-
as in nutrient assimilation” [12]. We will refer to this paper in detail later.
Here we have to mention that, for the first time, diabetes has been pre-
sented not as a disorder of carbohydrate metabolism, but as a disorder of 
an entire energy metabolism of the human body, including also lipid and 
protein metabolism. In fact, such interpretation made an important shift in 
diabetes paradigm, whose importance was understood as such only in the 
last decade when the researchers became aware that diabetes was not only 
”mellitus”, but also ”proteinus” [13] and ”lipidus”[14].
When this new concept of diabetes has been born? It is difficult to say. 
The first written document from Paulescu’s papers dated back from 1907, 
when in the “Handbook of Physiology” (990 pages in Romanian) we found the 
following sentence [26]:
“The pancreas plays an important role as a gland with external secretion; 
apart this function, it also plays an important role as a gland with internal 
secretion, function discovered by Lancereaux in 1877, in diabetic patients, 
when he found their pancreas to be altered.
In the pancreatic diabetes the man had either progressively or suddenly, an 
extraordinary thirst, which cannot be relieved. The urine contains a large 
quantity of glucose; also, the quantity of the eliminated urea is increased up 
to 150 g/day. Concomitant with that, the patient had intense hunger, and de-
spite a high food intake, he continually lost weight, a prove that assimilation 
cannot be made (or underlined). And then:
“The total ablation of the pancreas induces the same type of diabetes as that 
of humans: glucose, urea, hunger, thirst and death”.
In a subchapter, “The cause of pancreatic diabetes”, Paulescu wrote:
“Ligating Wirsung duct in dogs, diabetes did not appear; so, the pancreatic 
diabetes is not due to non-penetration of pancreatic juice in the intestine. By 
removing the head of the pancreas and its duct, we don’t obtain diabetes. 
Moreover, if we introduce a piece of pancreas under the skin, and after a 
while we remove the pancreas, we also cannot obtain diabetes.”
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In the last paragraph of this chapter, he concluded: 
“So, the pancreas is a gland with internal and external secretion. The inter-
nal one plays a role in preparing glucose for its assimilation. When the 
pancreas is removed, the liver cannot store glucose as glycogen.“ [16,17]
In order to more precisely place the moment when Paulescu arrived at a 
conviction of the fundamental role of the pancreas in glycogen homeostasis, 
we need to refer to a series of experiments effected by him between 1903-1911, 
when he perfected the original surgical technique of total pancreatic abla-
tion, associated sometimes with the extirpation of a hepatic lobe in order to 
study the effect of pancreatectomy on hepatic glycogen in diabetic dogs as 
well as in “fluorizinic” diabetes [17-23].
“Following total pancreatic ablation, the power of the liver to store glycogen 
is considerably reduced”. “Less affected is muscular glycogen and totally un-
affected is myocardial glycogen”. “In pancreatectomised dogs, the capacity 
of the tissues to store glycogen is not totally lost only diminished. This is a 
secondary phenomenon - that is, a consequence not a cause of diabetes.”
On this occasion Paulescu discovered the ”incretine effect” following the 
observation that the intraportal administration of glucose has any effect on 
the glycogen accumulation in the liver, in contrast with the same amount of 
glucose, administered orally induces a rapid accumulation of glycogen into 
the liver [23,24].
A more comprehensive description of diabetes appeared in the 3rd vol-
ume of the “Traité de Medicine Lancereaux –Paulesco”, Paris 1912 [25]. From the 
chapter entitled “The Pancreas”, and the subchapter ‘Physiology” (pages 925-
927) the following text is reproduced:
“II. Apart from the role played by the pancreas in processing food for their 
absorption, it carries out an equally important function through which it 
participates in the preparation of these absorbable substances, especially of 
carbohydrates, for their utilisation.
Lancereaux was the one who, in 1877, brought this hitherto only suspect-
ed function to light by describing a form of diabetes whose pancreases 
were affected by a morbid process. He felt that this form of diabetes was a 
consequence of functional suppression of the pancreas and he named it 
PANCREATIC DIABETES (E. Lancereaux. Bull. Acad. Medicine, 1877, 
page 1215)
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Only twelve years later in 1899, two physiologists (von Mering and 
Minkowski), carried out total ablation of the pancreas in dogs obtaining in 
these animals, a form of diabetes analogous to that in man and confirmed, in 
an experimental manner, Lancereaux’s earlier clinical conclusions.
We will return to pancreatic diabetes in humans later (page 933). For now, 
we shall report several experiments which help to elucidate the pathogenesis 
of this important syndrome permitting us to understand it.
Total or subtotal pancreatic ablation leads to the appearance of severe di-
abetes, which consists of considerable hyperglycaemia, azoturia (urine urea 
nitrogen) and polyphagia. Although they eat a lot, the operated animals lose 
weight rapidly and die in a state of cachexia. Very frequently, the healing of 
the operation sites is very slow or does not occur at all.
Partial ablation of the pancreas does not lead to diabetes, if the part remain-
ing does not have less than one-tenth of the weight of the organ. If the frag-
ment remaining does not reach this dimension, a more or less profuse post-
prandial glycosuria results, that is, the appearance of glucose in the urine, 
especially after a meal rich in carbohydrates.
 Ligation and resection of the excretory ducts of the pancreas are not fol-
lowed by diabetes. The same happens after extirpation of the entire duo-
denal portion of the organ if the portion remaining in the abdomen is suffi-
ciently voluminous - even though it is lacking in the excretory canals which 
drain its secretions into the duodenum. Thus, diabetes is not a consequence 
of a defect in the flow of pancreatic juice into the duodenum; in other words, 
it is not a consequence of the suppression of the pancreas̀  exocrine secretion.
These experimental facts also prove that the lesions of the abdominal ner-
vous plexuses occasioned by the extirpation of the pancreas play no role in 
the onset of diabetes as some authors claim.
Now, the question is: how does an endocrine suppression of the pancreas 
cause diabetes? Many hypotheses have been propounded to answer this ques-
tion, but not one of them has a solid and indisputable basis.
Grafting of the pancreas and the fact that the liver and muscles of depan-
creatised animals no longer contain glycogen have made us admit that until 
we have new data, the products of the internal secretion of the pancreas act 
on sugar - which is carried to the liver through the blood of the portal vein- 
and leads to some modifications which permit it to be first metabolised - that 
is, to be stored as glycogen by the liver, muscles etc. - and later to be utilised 
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(consumed) by the tissues. In the absence of the endocrine secretion of the 
pancreas, the sugar from the blood, being unassailable, is no longer fixed (in 
the liver) in the form of glycogen, nor utilised by the tissues. It accumulates 
in the blood (hyperglycaemia) producing osmotic effects (dehydration of the 
tissues, polydypsia) and being unusable (weakness, azoturia (urine urea ni-
trogen) and polyphagia), is eliminated in the urine (glycosuria) as a foreign 
body.” A wonderful synthesis of the pathophysiology of diabetes, which can 
be reproduced in any handbook of diabetes even today. 
The experimental demonstration of the new paradigm
According to our knowledge today, diabetes expresses a complex disor-
der of the energy metabolism, i.e. a defect in the peripheral utilization of all 
energy fuels: carbohydrates, lipids and proteins. This definition confirms the 
100-year old vision of Nicolae Paulescu, the man who changed the paradigm 
of diabetes, considered until then a disorder affecting only the carbohydrate 
metabolism, into a disorder in the utilization of all energy fuels.
In order to understand Paulescu’s manner of thinking and acting, it must 
be said that his first source of information was the careful analysis of dia-
betic patients. Like a detective who has some indirect clues related to the 
guilty and gathers meticulously the evidence leading to the right conclusion, 
Paulescu used clinical and biochemical observations of human diabetes, but 
also the symptoms appeared after total pancreatectomy in dogs. He observed 
that the symptoms of diabetes can be explained by an accelerated catabolism 
of proteins (weight loss) and the accumulation in the circulation of biochem-
ical compounds, such as glucose and ketone bodies demonstrating the defect 
in their utilization in peripheral tissues. The second information comes from 
the symptoms appearing after total ablation of the pancreas: the sudden on-
set of the same symptoms. Paulescu noted that the use of all fuels in the tis-
sues is affected.
In order to demonstrate that this defect is due to the absence of the an-
tidiabetic pancreatic hormone, he assumed that its intravenous administra-
tion should lead to the correction of all three changes (in glucose, lipids and 
proteins) in blood and urine considered by him to be the “cardinal symptoms 
of diabetes”.
From his published papers we can reconstitute the experiments he used: 
total pancreatic ablation of healthy dogs, in order to induce experimen-
tal diabetes; extraction from the pancreas of “the antidiabetic substance” 
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(unknown at that time) using an original method, giving maximal attention 
to aseptic measures and the respecting the conditions that would preserve 
the active principle (temperature below 50º C). A such extract to demon-
strate its effects on blood and urinary glucose, ketone bodies and urea.
In 1916, towards the end of his experiments in which this hypothesis was 
validated, his research was interrupted by the 1st World War. Laboratories 
were closed and the publication of his work done till then in an internation-
al journal was impossible. This is the reason why the data obtained by him 
before the War (with the exception of the effects on ketone bodies) appeared 
in an exhaustive form in the 2nd volume of “Traité de Physiologie Médicale”, 
published in 1920 in French [26].
At the end of this chapter, Paulescu made very clear the following state-
ment: “This discovery, which sheds a new light on the pathogenesis of diabetes, 
also gives us the key to the treatment of this syndrome.”
After the reopening of laboratories in 1921, Paulescu demonstrated the 
last effect of Pancreine on ketone bodies, also experimentally proving the 
specificity of the effects, that were not noted after the administration other 
organs̀ extracts, or by inducing a bout of fever with pyrogenic substances. 
These data were published in 4 short papers on 27 July 1921 in the outstand-
ing publication of the Biology Society in Paris (Compte Rendu de la Société 
de Biologie du Paris) [8-11], and finally, in a more comprehensive manner, in 
International Archives of Physiology (Archives International de Physiologie) 
(Liège, Paris), on 31 August 1921 [12]. The conclusions of this famous paper 
which can be considered the “true insulin’s birth certificate” were:
I. “If in an animal, with diabetes induced by ablation of the pancreas, a pancre-
atic extract is injected into the jugular vein, we observe:
a). Diminution and temporary suppression of hyperglycaemia, which may be 
replaced by hypoglycaemia and a diminution or even temporary suppression 
of glycosuria;
b). Considerable diminution of blood urea and urinary urea;
c). Marked diminution of ketonaemia and ketonuria.
II. The effect of the pancreatic extract on glycaemia and glycosuria varies with 
the interval of time following the injection, beginning immediately after the injection 
and reaches a peak at about 2 hours and lasts about 12 hours.
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The effect also varies with the amount of pancreas used for preparing the 
extract.
III. If in a normal non-diabetic animal a pancreatic extract is injected into a 
vein, a marked diminution of glycaemia, blood urea and urinary urea is noted.
IV. Similar effects, influencing especially diabetic hyperglycaemia and glycos-
uria are not produced by either:
a. i.v. injection of a saline solution;
b. i.v. injection of an extract of an organ other than the pancreas;
c.  Or intraspinal injection of a sodium nucleate solution causing a bout of 
fever.”
We do not believe that a single line of this “Certificate” can be contested. 
All the metabolic functions of the newborn hormone were clearly described 
in such a manner that they remain as we know even today. As happened with 
many visionary concepts, this view was over sides by Paulescù s contempo-
rary. This paper had been published 8 months before the first experimental 
work of Banting and Best in February 1922, and was known by at least three 
of the Canadian team (Macleod, Banting and Best), according to the written 
documents from the Bliss book [1].
How aware of Paulescu’s work was the Canadian team?
In his book [1], Michael Bliss tried to convince us that Paulescu’s work 
was not known by North-American researchers, including the Canadian 
team. Nothing could be more wrong. As early in November 1921, Ernest 
Lyman Scott (1877-1966) (who produced a pancreatic extract years earlier) 
sent to Paulescu a congratulatory letter for his paper published in 1921. John 
Raymond Murlin, another known researcher in the field, stated in 1923, that 
he resumed his research on the pancreatic extract stimulated by Paulescu’s 
papers. In their first paper, published in February 1922 Banting and Best, 
quoted Paulescù s papers [5,6,8] in a strange manner:
“Paulescu has recently demonstrated the reducing effect of whole gland 
extract upon the amounts of sugar, urea and acetone bodies in the blood 
and urine of diabetic animals. He states that injections into peripheral veins 
produce no effect and his experiments show that second injections do not 
produce such marked effects as the first.”
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This obvious misrepresentation of Paulescu’s very clear data has not been 
explained till today. It has been suggested that the ignorance of “young re-
searcher” stayed at the base of this ignoble misrepresentation. If they were 
such ignorant, how they received one year later the Nobel Prize? To my mind, 
the distortion of Paulescu’s work was deliberately done to distract the atten-
tion from the inconvenient fact that the discovery of insulin had already 
been achieved.
Referring to the Macleod, Bliss stated: “Perhaps as commonly happens with 
even the best informed professors, Macleod had not yet read Paulesco.” (“Discovery 
of Insulin” by Michael Bliss, page 208). Macleod itself contradicted this claim 
in 1926 in the book “Carbohydrate metabolism and insulin”, referring to the 
work carried out in Toronto, he said:
“While this work was in progress in Toronto, a paper by Paulesco came to 
our notice and after it was complete, one by Gley. Paulesco‘s researches were 
communicated at the meeting of Reunion Roumaine de Biologie in spring of 
1921 in which he described the effects produced by intravenous injection of 
sterile pancreatic extracts on the percentage of sugar, of acetone bodies and 
of urea in the blood and urine of depancreatised dogs. Typical observations 
are shown in tables 1, 2 and 3.
There can be no doubt that all three substances became markedly reduced in 
amount in both blood and urine, as a result of the injection. The results were 
the same whether the injection was made into a branch of the portal vein 
or into the jugular vein. The effects were noticeable in one hour following 
the injection, attained their maximum in two hours and passed off in twelve 
hours. They varied with the amount of gland present in the injected extract. 
Paulesco also observed that the blood sugar as well as the blood urea in a 
normal dog became lowered by the injection. No observations are recorded 
of the behaviour of the respiratory quotient or of the glycogen content of the 
liver and no evidence is given that the general symptoms of diabetes were 
lessened or the life of the animal prolonged.”
In fact, Macleod read Paulescu’s paper during his holiday in Europe, and 
from that time he realized, for the first time, that Banting’s idea to prepare a 
pancreatic extract from duct-ligated pancreas, to be used in diabetes, could 
work. Paulescu’s papers convinced him that the internal secretion is a reality. 
So, returning to Toronto in 1921, he took the initiatives, asking Collip to join 
the team as soon as possible. Already in November 1921, he sent a letter to 
Joslin saying:
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“It is true that we have been doing work on the influence of Pancreatic ex-
tracts, which has yielded most encouraging results, but I would rather hes-
itate to attempt the application of these results in the treatment of human 
diabetes until we are absolutely certain of them. Dr. Banting and Mr. Best 
who have been doing this work, are to report their findings at the meeting of 
the Physiological Society at New Haven, by which time we expect to be in a 
position to come to a definite conclusion. I may say privately that I believe we 
have something that may be of real value in the treatment of Diabetes and 
that we are hurrying along the experiments as quickly as possible.” [Bliss, 
page 96].
This text demonstrates that the “race against time” had commenced 
in the summer of 1921, when Macleod sent to Banting and Best the ex-
perimental method used by Paulescu and coincidentally, at the end of the 
summer, they totally changed their complicated protocol, adopting with-
out any explanation, exactly the method used by Paulescu. It is our feeling 
that Macleod proposed to Banting and Best this new experimental proto-
col, without mentioning that this originated from Paulescu’s work. Macleod 
understood that the discovery of insulin had been done, but the utilization 
of this discovery in the treatment of diabetes was not reported by Paulescu. 
Thus, when he invited Collip to join the team, his aim was specifically the 
purification of the pancreatic extract for the purpose of administrating it in 
man. Banting lacked the finesse to understand their real position in this “in-
sulin affair”, but he instinctively felt that the clinical application would be 
a very important step. It was not by chance that in the period of December 
1921 and February 1922, Collip approached those aspects of Paulescu’s work, 
such as the antiketogenic effect of the pancreatic extract which Banting and 
Best had not studied. To their surprise, Macleod brought up for discussion 
these effects at the Physiology Reunion in New Haven on 30 December 1921, 
when the Canadian team orally presented the results of their work till then. 
The patent of “Pancreine”: 10 April 1922
Since 1920 Paulescu thought that his new hormone, Pancreine, is also the 
key element in the treatment of diabetes, and he considered preparing a pat-
ent for the new product. Soon after the end of his experiments, Paulescu 
applied in Bucharest on 10 April 1922 for a patent named „Pancreine and the 
process of its fabrication” [27], the clearest proof of his aim to use the hor-
mone in the treatment of diabetes. The content of this patent was based on a 
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parallel work done by him in a biochemistry laboratory. The reader is invited 
to observe the clarity of this text, its biological expertise of the author and 
its sense of responsibility for a product intended to be used in human being.
 His efforts in 1922 were directed towards the technical problems related 
to the purification of his pancreatic extract. After many trials, he obtained a 
rather highly purified extract which he described in his application for a pat-
ent. The approval of its application would come on 10 April 1922 as patent no. 
6254. Here is the full text of this patent which includes, in the method of its 
purification, two additional steps to the procedure he used in obtaining the 
extract in 1921. For this reason, the solution containing the extract was ex-
tremely powerful and could produce very low blood sugar levels, sometimes 
below the detection limits of the methods used by Paulescu (called “aglycae-
mia” by him). Later, Collip made the same observations using his purified ex-
tract prepared at the beginning of 1922. Bearing in mind the modest facilities 
at his disposal, Paulescu’s observations highlight even more the accuracy of 
his methods and the keenness of his spirit of observation. 
PANCREINE  
and the process of its production 
“I give this name to the active principle discovered by me in the extract of the 
pancreas. See: Paulescu Recherché sur le rôle du pancrèas dans l’assimila-
tion nutritive, in Archives Internationales de Physiologie, Liège, Vol XVII, 
p. 85.
This substance has remarkable properties which, when injected into the blood 
of an animal rendered diabetic by extirpation of the pancreas produces:
a.  a diminution or even a transient suppression of hyperglycaemia and 
glycosuria; 
b.  a diminution in blood and urinary urea; 
c.  a diminution in blood and urinary acetone; 
In order to isolate Pancreine as much as possible from other proteins, I pro-
ceed in the following manner: 
Observing strict antisepsis, I take a certain portion of the fresh pancreas 
from a recently sacrificed animal. 
The gland is well minced in a Broyeur Latapie machine and sterilised in an 
oven. 
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To this minced pancreas is added ten times its weight in distilled water, after 
which I shook it many times and introduced it into a cooler.
After several hours, 6 - 24, the minced pancreas is filtered through a sterile 
double gauze compress in order to remove the very voluminous solid parts.
The filtrate, which is cloudy, is more or less rose in colour and to it is added 
pure hydrochloric acid 10 pp 1000, which brings on an abundant protein 
precipitate.
The grey precipitate is separated with a sterile gauze filter and, as the liquid 
is acid, it is neutralised using caustic soda. 
Thus a new and abundant protein precipitate is produced.
The new precipitate is separated using a Berzelius paper and sterilised. 
The filtered liquid is clear and transparent and still gives a protein 
reaction.
Finally, the volume of this liquid is reduced by evaporation at a temperature 
which must not exceed 50°C.
In order that pancreine be used in the treatment of human diabetes, it must 
be prepared in large quantity, which requires a lot of capital. 
In addition, it is absolutely necessary that strict measures for antisepsis be 
observed in making this preparation.
At the same time, all the physico-chemical requirements of the process must 
be carefully observed especially that the liquid temperature does not exceed 
50°C. 
If these diverse steps are not very rigorously followed, the medicine may be-
come either a focus of infection, thus bringing about a disaster or it loses its 
physiologic action. In order to ensure the fulfilment of this fundamental 
condition of preparation as well as to maintain the scientific standard of the 
product thought it necessary to demand a patent. 
Claim 
 I claim the invention of the organic pancreatic product which, when inject-
ed into the blood, produces a diminution or even a transient suppression of the 
symptoms of diabetes.” 
Sgd N.C. Paulescu”
 Because in 1920, Paulescu already anticipated that the pancreatic ex-
tract is the key in the treatment of diabetes, Canadians understood that the 
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utilization of pancreatic extract by Paulescu is imminent. This explains the 
acceleration of the work in Toronto, the fact that created an open conflict 
between Banting and Best, on the one side, and Macleod and Collip, on the 
other side. The key person in this step was Collip, who in less than 2 months, 
succeeded to purify the pancreatic extract. After a physical aggression of 
Banting against Collip, although frightened, he remained in Toronto several 
months, producing the first quantities of extract (“Isletin” called that time) 
with which all patients in the initial clinical trials were treated. As Bliss said 
(page 238): ”In later years, Collip was very reluctant to talk or write about the dis-
covery of insulin, saying that the truth was to be found in the scientific publications 
and might emerge after they were all dead.”
In an interview for the Star in September 1922, he said: “There are some 
people in Toronto who felt that I had no business to do physiological work. Against 
this I would say that when I entered the collaborating group early in December 1921, 
it was with a view of putting my whole effort into pushing forward of the research 
irrespective of any water-tight compartments. The result was that when I made a 
definite discovery, my confreres instead of being pleased were quite frankly provoked 
that I had had the good fortune to conceive the experiment and to carry it out. My 
own feelings now in the matter are that the whole research with its aftermath has 
been a disgusting business.”
This bitter word is understandable because the full merit for utilization 
of insulin in Toronto belongs to Collip. Instead, Banting negotiated in the 
middle of September with Eli Lilly Company to transfer the production of 
insulin in order to remove Collip from the team, so that he could be the only 
owner of the method of insulin preparation. In fact, he robed Paulescu’s 
work, which had led to the discovery of insulin, and also Collip’s purifica-
tion method of pancreatic extract.
If the Nobel Prize was awarded for the clinical application of the discov-
ery of insulin (which belongs to Paulescu) then Collip should have been tak-
en into consideration for the Nobel Prize Award. In fact, the Nobel Prize was 
attributed to persons (Banting and Macleod), who did not deserve it.
How did the wrongful awarding of the Nobel 
Prize influence the diabetological thinking?
Since the destiny decided that Paulescu will be punished for his audacity 
to discover one of the most hidden secrets of life, his magnificent researches 
from 1916-1923 were neglected, the focus of attention being fixed on those 
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that received the Nobel Prize. They were the new prophets of science, and 
only their ideas should be considered. Since Banting and MacLeod thought 
in the old paradigm of diabetes, many years after the discovery of insulin, 
the study of the new hormone was strictly focused on its glucose lowering 
effects and diabetes continued to be identified with hyperglycaemia. In fact, 
hyperglycaemia remained for 100 years the only criterion for the diagnosis of 
this immense syndrome, conceived by Paulescu in a much larger biochemical 
perspective.
As we mentioned before, research-
ers progressively realised that diabe-
tes is much more than a disorder of 
carbohydrate metabolism (diabetes 
mellitus), and they stated that diabetes 
can be equally considered as diabetes 
lipidus [14] (lipid disorders being indis-
solubly linked to this syndrome) and 
diabetes proteicus due to the important 
protein metabolism alteration [13]. The 
last term, proposed in a presentation 
of Marliss during the IDF Congress 
in Cape Town in 2006, confirmed in 
fact the vision that Paulescu had in 
1912. Despite this, at that moment no-
one made reference to the papers of 
Paulescu and his discovery of the anti-diabetic hormone. It is currently well 
known that the numerous attempts to publish the truth in the major diabeto-
logical journals (Diabetes, Diabetologia, Diabetes Care) faced a cunningly jus-
tified refusal: the above mentioned journals do not have the aim to publish 
historical points of view. This long lasting resistance is illustrated by the ma-
jor difficulties faced between 1969-1971 by the Scottish historian Ian Murray 
(1899-1974), an important personality of diabetology during those times, who 
published the first papers that demonstrated the priority of Nicolae Paulescu 
in the discovery of insulin [28-30]. This attitude was manifested by an in-
ternational personality absolutely impartial, pleading in favour of Paulescu 
only in the spirit of fairness that should be present in the scientific commu-
nity. Ian Murray makes a breach in the embargo on discussing the conflicts 
inside the Canadian group that took place between 1922-1923. Despite the 
fact they were mentioned only with silence, details regarding the violence of 
Figure 2. N.C. Paulescu in 1928.
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Banting towards the other members of the team were well known. In time, 
the breach created by Ian Murray became a large rift through which, nowa-
days, flows the large river of truth.
However, with the occasion of celebrating 75 years from insulin discov-
ery, Korec R. presented a paper showing that using a protocol for obtaining 
an active pancreatic extract (similar to the patent of Paulescu) in a diabetic 
animal model, the administration of Pancrein had a significant effect on gly-
cemia [31].
The resistance of the North-American diabetologic community regard-
ing the interventions of Prof. Ion Pavel (1897-1991) in favour of Paulescu be-
tween 1971-1973 were even stronger and, I could say, more and more refined. 
This can be clearly seen from the correspondence on this topic of Prof. Pavel 
with different members of the international diabetes societies of those times. 
He published this correspondence in two books [32,33]. His disappointment 
can be illustrated by his conclusion from the cover of the last book:
“I devoted all my efforts for the last two decades to the recognition of the 
priority of N.C. Paulescu in the discovery of insulin. Analysing today the cir-
cumstances that for 65 years wrong this great scientist, I find out that, finally, 
this injustice is the result of a grievous lack of scientific ethics”.
 If there still is a lot of scepticism on the total reconsideration of the truth 
regarding the discovery of insulin, our optimistic point of view was already 
expressed in 1996, with the occasion of the 75 year anniversary of insulin 
discovery [2]. We were, and we still are convinced that time is on Paulescu’s 
side and it favours him. This is proven by the fact that at the International 
Diabetes Federation Congress in Montreal in October 2010, Prof. Alberto 
de Leiva, in a wonderful lecture regarding the history of diabetes, put in a 
correct light the outstanding contribution of Paulescu’s work in the insulin 
discovery from 1921. In addition, in two books regarding the history of dia-
betes published in 2009 [33,34], as well as in an important Diabetes Textbook 
published in the UK in 2010 [35], the results of Paulescu with their true rele-
vance and his portrait appear constantly before those of the Canadians.
 Conclusion
Controversies regarding the scientific discovery cannot be impartially 
established, without taking into account two objective criteria: (1) the date 
of publication in international journals, and (2) the scientific value of the 
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data. Using these criteria, discovering of the antidiabetic hormone, finally 
called the “insulin”, and describing all its physiological properties was done 
by N. C. Paulescu with more than half a year before the Canadian team. The 
therapeutic application of this discovery was successfully implemented on 23 
January 1922 using a purified pancreatic extract prepared by Collip.
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Sažetak
Svrha je ovog članka opisati istraživanje Nicolaea Constantina Paulescua i istaknuti njego-
vu ulogu u otkriću inzulina. 
Metode: Temeljito smo pregledali literaturu i istraživanja u rumunjskoj akademskoj arhivi 
kako bismo pronašli odgovarajuće reference. 
Rezultati: N. C. Paulescu je 1912. analizirao kliničke i biokemijske promjene kod pacijenata 
s dijabetesom i kod pasa nakon izvođenja pankreatektomije, koji su osim hiperglikemije i gli-
kozurije (metabolizam ugljikohidrata) zabilježili i promjene u metabolizmu lipida i proteina. 
Godine 1916. Paulescu je započeo eksperiment s ekstraktom gušterače dobivenim njegovom 
izvornom metodom, koji je intravenski ubrizgan u pse koji su bolovali od dijabetesa. Rezultati 
njegovih prvih eksperimenata pokazali su: “Ekstrakt gušterače ubrizgan u perifernu venu 
proizvodi: 1. smanjenje, pa čak i privremenu supresiju dijabetičke hiperglikemije, koja može 
biti zamijenjena hipoglikemijom; 2. smanjenje ili čak privremenu supresiju glikozurije; 
3. smanjenje uree u krvi; 4. smanjenje uree urina. Drugim riječima, intravenozna injekcija 
ekstrakta gušterače ima za posljedicu nestanak simptoma dijabetesa. Smanjenje dijabetič-
kog sindroma počinje odmah nakon ubrizgavanja, a maksimum doseže nakon dva sata – i 
traje oko 12 sati.” Zaključio je: “Ovo otkriće, koje baca novo svjetlo na patogenezu dijabetesa, 
daje nam i ključ za liječenje ovog sindroma.” Paulescu je 1921. objavio svoje podatke u dva 
izvanredna francuska časopisa i to osam mjeseci prije prve publikacije Bantinga i Besta u 
veljači 1922. Jasno je da je inzulin otkriven u Europi. 
Zaključak: Paulescu je smatrao da je novootkriveni hormon, nazvan pancrein, ključni ele-
ment u liječenju dijabetesa, ali njegovo izvanredno istraživanje nepravedno je zanemareno.
Ključne riječi: otkriće inzulina; medicinska etika; kronologija događaja i kontekst; eksperi-
mentalni dizajn.
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